Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × talimogene laherparepvec × 90 days × Clear all

Sponsor

Conditions

Sarcoma 3 Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Paget Disease, Extramammary 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma 1 Mycosis Fungoides 1 Muir-Torre Syndrome 1 Microcystic adnexal carcinoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Eccrine Porocarcinoma 1 Carcinoma, Signet Ring Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Carcinoma, Basosquamous 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Adenocarcinoma, Papillary 1

Interventions

Specimen Handling 5 Tamoxifen 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 2 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Telemedicine 1 Starch 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Genotype 1 Gels 1 Educational Status 1 Early Intervention, Educational 1 Diet Therapy 1 Diet 1 Biopsy 1 Behavior Therapy 1 Anesthesia, General 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡